HCW Biologics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HCW Biologics and other ETFs, options, and stocks.About HCWB
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases. The firm considers age-related low-grade chronic inflammation as a contributing factor to several chronic diseases and conditions, such as cancer, cardiovascular disease, diabetes, neurodegenerative diseases, and autoimmune diseases.
CEOHing C. Wong
CEOHing C. Wong
Employees36
Employees36
HeadquartersMiramar, Florida
HeadquartersMiramar, Florida
Founded2018
Founded2018
Employees36
Employees36
HCWB Key Statistics
Market cap4.38M
Market cap4.38M
Price-Earnings ratio-0.11
Price-Earnings ratio-0.11
Dividend yield—
Dividend yield—
Average volume55.36K
Average volume55.36K
High today$1.69
High today$1.69
Low today$1.57
Low today$1.57
Open price$1.57
Open price$1.57
Volume15.87K
Volume15.87K
52 Week high$41.20
52 Week high$41.20
52 Week low$1.52
52 Week low$1.52
Stock Snapshot
With a market cap of 4.38M, HCW Biologics(HCWB) trades at $1.62. The stock has a price-to-earnings ratio of -0.11.
On 2025-12-22, HCW Biologics(HCWB) stock traded between a low of $1.57 and a high of $1.69. Shares are currently priced at $1.62, which is +3.2% above the low and -4.0% below the high.
The HCW Biologics(HCWB)'s current trading volume is 15.87K, compared to an average daily volume of 55.36K.
In the last year, HCW Biologics(HCWB) shares hit a 52-week high of $41.20 and a 52-week low of $1.52.
In the last year, HCW Biologics(HCWB) shares hit a 52-week high of $41.20 and a 52-week low of $1.52.
People also own
Based on the portfolios of people who own HCWB. This list is generated using Robinhood data, and it’s not a recommendation.